Upping its game against certain candida, tuberculosis and gonorrhea strains, the U.S. Centers for Disease Control and Prevention recently allotted more than $200 million to help jurisdictions curtail both emerging and re-emerging infectious diseases. Read More »
The U.S. Food and Drug Administration is creating new regulation on tobacco and nicotine to reduce diseases and death brought on by tobacco use. Read More »
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt has written directly to U.S. Food and Drug Administration Commissioner Scott Gottlieb to offer the association’s concise solution for fast-tracking “common-sense” improvements to the nation’s opioid abuse policy. Read More »
GSK (GlaxoSmithKline PLC) recently commenced follow-up to approval gained from the U.S. Food and Drug Administration for shipping vaccines combating influenza to nationwide health care providers in advance of the 2017-18 flu season. Read More »
Suggesting ways to reduce prescription drug costs plus overall marketplace guidance, the Pharmaceutical Care Management Association recently wrote to Health and Human Services Secretary Tom Price, detailing potential pricing and savings allocation improvements. Read More »
"Drug manufacturers, wholesalers, pharmacies, and insurance companies are just some of the entities that should be involved in finding a true market solution" to drug pricing," writes Dr. Kathleen Iacocca, professor at Villanova University School of Business. "The industry has to change itself to avoid Washington interference and all of those impacted need to be equally involved." Read More »
One in four Americans taking certain prescribed medicines say they would stop taking them immediately—without consulting their doctor—after seeing ads promoting lawsuits against the drugs’ manufacturers, according to a new national survey released by the U.S. Chamber Institute for Legal Reform (ILR). Read More »
Do television ads by plaintiffs' lawyer firms hawking lawsuits over prescription drugs cause patients to cease taking their prescribed prescriptions? Read More »
The Health Affairs Blog, a vehicle for commentary on health policy and issues affecting the health care industry, recently release an article on surprise medical bills. Read More »
After documenting recent product abuse, the U.S. Food and Drug Administration asked Endo Pharmaceuticals to voluntarily remove its reformulated Opana ER (oxymorphone hydrochloride) opioid medication from circulation, stating that risks may now outnumber benefits. Read More »
The Health Affairs Blog, a vehicle for commentary on health policy and issues, recently wrote about how the Cures Act and FDA Draft Guidance suggest flexibility on communication of real-world drug impacts. Read More »
Government-mandated disclosure bills could have a negative impact on competition if pharmacy benefit managers are forced to publicly disclose too much information on their negotiations with drug companies, according to Emory School of Law professor Joanna Shepherd. Read More »
The U.S. Supreme Court issued a 9-0 ruling today that will have the effect of speeding the process for biosimilars going to market. Read More »
As a Senate committee prepares to evaluate U.S. drug distribution at a hearing tomorrow, the Pharmaceutical Care Management Association readily demonstrates that manufacturers’ pricing does not correlate with agreed-upon rebates and discounts with pharmacy benefit managers. Read More »
The Centers for Medicare and Medicaid Services recently authorized Texas-based McKesson Specialty Health as a Qualified Clinical Data Registry, rendering it eligible to participate in the Merit-Based Incentive Payment System for 2017. Read More »
Panacea Pharmaceuticals has filed a U.S. patent application for Immune System Enhancing Immunotherapy for the treatment of cancer. Read More »
Fred’s Inc.'s plans to buy 865 Rite Aid stores for $950 million is still active. Read More »
The cost of generic prescription drugs rose at a much slower rate than brand name drugs in 2016, according to an annual national drug index released by Truveris. Read More »
The Academy of Managed Care Pharmacy's members are urging Congress and President Donald Trump's administration to include comprehensive pharmacy benefits in any health care reform bill they attempt to pass. Read More »
Waismann Method Medical Group directors have warned of a new naloxone-resistant drug hitting the streets, calling for an awareness program for acrylfentanyl and warning of a serious public health emergency. Read More »
Alerts Sign-up
